Frederic Heimgartner

Title: Frederic Heimgartner: Innovator in Pharmaceutical Composition

Introduction

Frederic Heimgartner is a notable inventor based in Marin-Epagnier, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of slow-release compositions.

Latest Patents

Heimgartner holds a patent for a slow-release pharmaceutical composition made of microgranules. This innovative composition is designed for the slow release of an active substance over a period that covers at least six months after injection. The composition includes microparticles made of a copolymer of the PLGA type, which incorporates a water-insoluble peptide salt. The copolymer consists of at least 75% lactic acid and has an inherent viscosity between 0.1 and 0.9 dl/g. The microparticles have a specific size distribution, ensuring effective delivery of the active substance.

Career Highlights

Frederic Heimgartner is associated with Debiopharm Research & Manufacturing SA, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has led to advancements in drug delivery systems, enhancing the efficacy of treatments.

Collaborations

Heimgartner collaborates with esteemed colleagues such as Bertrand Ducrey and Patrick Garrouste, contributing to a dynamic research environment that fosters innovation.

Conclusion

Frederic Heimgartner's work in developing slow-release pharmaceutical compositions exemplifies his commitment to advancing medical science. His contributions are vital in improving patient outcomes through innovative drug delivery methods.